For years, molecular workflows have followed the same limiting path. Collect samples, transport to a central lab facility, extract nucleic acid, run the test and wait for the result. Hours pass, sometimes days. During that time, transmission continues, risk increases, downstream costs accumulate and lives are lost. The real constraint is not the underlying science. It is the restrictive workflow and process requirements.
CENOS removes the most entrenched step in molecular testing - extraction. The patented Xtraction-Free reagent system delivers direct RT-qPCR from crude biological samples. Whole blood, saliva, swabs, plasma, and tissue can all be directly added to the reaction for testing.
Xtraction Free Workflow
Our proprietary Xtraction Free Reagent System simplifies and accelerates real-time qPCR testing, with no need for cold-chain storage, sample transportation or upstream purification. The streamlined workflow is a controlled and repeatable process that can be performed in any environment by anyone in just 3 simple steps - test to result in under 30 minutes:
Molecular Testing Where It Matters
CENOS operates without the need for laboratory infrastructure or specialist personnel. The portable analyser can be used by trained users in decentralised settings providing superior operational flexibility. Testing can be migrated from central lab facilities to the Point-of-Decision, exactly where it is needed - whether that is a community clinic, farm, remote village or forward operating base.
This shift becomes critical when viewed from a One Health approach. Over 65% of emerging pandemic-potential diseases originate from animals, yet most systems still rely on centralised confirmation before taking action. By the time a result arrives, the opportunity to contain a disease outbreak has often passed. When disease spreads, the impact reaches income, food systems, and community resilience. Delay the answer, and you amplify the damage.
The CENOS platform helps to break the transmission cycle at the source - before diseases can cross species and become a serious threat. Targeted testing of humans, animals and the environment helps to address the full spectrum of disease control - contributing to global health equity and security.
CENOS brings molecular precision to the Point-of-Decision — without compromise. Find out more at www.biogene.com
